LNAnteLTS:0OR2 +0.87%81 EV-to-FCF is 13.66 as of Jul. 01, 2026, which is 8% above its 10-year median of 12.67. GuruFocus rates LTS:0OR2 with a GF Score™ of 81/100 and a GF Value™ of €28.69 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 407 Healthcare Providers & Services companies, LNAnte ranks better than 58.72% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, LNAnte's Enterprise Value is €1,180.0 Mil.
LNAnte's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €86.4 Mil. Therefore, LNAnte's EV-to-FCF for today is 13.66.
The historical rank and industry rank for LNAnte's EV-to-FCF or its related term are showing as below:
LTS:0OR2'
s EV-to-FCF Range Over the Past 10 Years
Min: 9.24 Med: 12.67 Max: 63.74
Current: 13.58
During the past 13 years, the highest EV-to-FCF of LNAnte was 63.74. The lowest was 9.24. And the median was 12.67.
LTS:0OR2's EV-to-FCF is ranked better than 58.72% of 407
companies
in the Healthcare Providers & Services industry
Industry Median: 17.51
vs LTS:0OR2: 13.58
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-01), LNAnte's stock price is €34.70.
LNAnte's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €2.354. Therefore, LNAnte's PE Ratio (TTM) for today is 14.74.
LNAnte (LTS:0OR2) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
LNAnte's share price for today is €34.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LNAnte's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €2.354.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
LNAnte EV-to-FCF Related Terms
LNAnte EV-to-FCF Historical Data
* Premium members only.
The historical data trend for LNAnte's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, LNAnte's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LNAnte EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LNAnte's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where LNAnte's EV-to-FCF falls into.
LNAnte's current Enterprise Value is €1,180.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. LNAnte's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €86.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LNAnte (LTS:0OR2) has a EV-to-FCF of 13.66 as of Jul. 01, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on LNAnte and its competitors. This is near median its historical median of 12.67. Over the past decade, LNAnte's EV-to-FCF has ranged from 9.24 to 63.74. According to the industry distribution chart, LNAnte ranks #168 out of 407 companies in the Healthcare Providers & Services industry, placing it in the top 41.3%.
Is LNAnte's EV-to-FCF too high?
LNAnte's current EV-to-FCF of 13.66 is near median its 10-year median of 12.67. Over the past 10 years, this metric has ranged from a low of 9.24 to a high of 63.74. The Healthcare Providers & Services industry median EV-to-FCF is 17.51. LNAnte's value of 13.66 is 22% below this industry median. Based on the distribution chart, LNAnte ranks #168 out of 407 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LNAnte has a GF Score™ of 81/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LNAnte's EV-to-FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, LNAnte ranks #168 out of 407 companies for EV-to-FCF. This puts LNAnte in the upper half of its industry. The industry median EV-to-FCF is 17.51. LNAnte's value of 13.66 is 22% below this benchmark. Historically, LNAnte's own EV-to-FCF has ranged from 9.24 to 63.74 over the past decade. While the company's 10-year median is 12.67 vs. the industry median of 17.51, LNAnte has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.51, based on 407 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LNAnte's current EV-to-FCF of 13.66 is 22% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on LNAnte and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LNAnte's current EV-to-FCF is 13.66, which is near median its own 10-year median of 12.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LNAnte stock overvalued right now?
Based on GuruFocus' analysis, LNAnte (LTS:0OR2) is currently considered Modestly Overvalued. The stock's GF Value™ is €28.69, compared to a current price of €34.70 — trading 20.9% above its estimated fair value. The current EV-to-FCF is 13.66, which is near median its 10-year median of 12.67 and 22% below the Healthcare Providers & Services industry median of 17.51. LNAnte's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For LNAnte (LTS:0OR2), the current EV-to-FCF is 13.66 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LNAnte (LTS:0OR2) Overvalued in 2026?
Based on GuruFocus' analysis, LNAnte stock appears to be overvalued.
The current stock price of €34.70 is trading 20.9% above its estimated GF Value™ of €28.69.
GuruFocus considers LNAnte to be Modestly Overvalued.
Key valuation signals for LTS:0OR2:
EV-to-FCF: 13.66 (near median its 10-year median of 12.67)
GF Value™: €28.69 vs. price of €34.70 (20.9% above fair value)
Industry Position: 22% below the Healthcare Providers & Services median (#168 of 407)
No single metric tells the full story. See the LTS:0OR2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LNA Sante SA is engaged in the management and operation of retirement homes, nursing homes, follow-up care clinics, rehabilitation centers, centers for the disabled and handicapped ageing.
81GF Score
Get the complete analysis for LTS:0OR2
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0OR2 has been successfully added to your 
